154 related articles for article (PubMed ID: 26938556)
21. Comparison of in vitro, animal, and clinical determinations of iron bioavailability: International Nutritional Anemia Consultative Group Task Force report on iron bioavailability.
Forbes AL; Arnaud MJ; Chichester CO; Cook JD; Harrison BN; Hurrell RF; Kahn SG; Morris ER; Tanner JT; Whittaker P
Am J Clin Nutr; 1989 Feb; 49(2):225-38. PubMed ID: 2644802
[TBL] [Abstract][Full Text] [Related]
22. In vitro evaluation of iron solubility and dialyzability of various iron fortificants and of iron-fortified milk products targeted for infants and toddlers.
Kapsokefalou M; Alexandropoulou I; Komaitis M; Politis I
Int J Food Sci Nutr; 2005 Jun; 56(4):293-302. PubMed ID: 16096139
[TBL] [Abstract][Full Text] [Related]
23. Iron fortification with special reference to the role of iron EDTA.
Bothwell TH
Arch Latinoam Nutr; 1999 Sep; 49(3 Suppl 2):23S-33S. PubMed ID: 10971833
[TBL] [Abstract][Full Text] [Related]
24. Stabilized-solubilized ferric pyrophosphate as a new iron source for food fortification. Bioavailability studies by means of the prophylactic-preventive method in rats.
Salgueiro MJ; Arnoldi S; Kaliski MA; Torti H; Messeri E; Weill R; Zubillaga M; Boccio J
Biol Trace Elem Res; 2009 Feb; 127(2):143-7. PubMed ID: 18802669
[TBL] [Abstract][Full Text] [Related]
25. Iron from complex salts and its bioavailability to rats.
Dutra-de-Oliveira JE; Freitas ML; Ferreira JF; Gonçalves AL; Marchini JS
Int J Vitam Nutr Res; 1995; 65(4):272-5. PubMed ID: 8789625
[TBL] [Abstract][Full Text] [Related]
26. Absorption of unlabeled reduced iron of small particle size from a commercial source. A method to predict absorption of unlabeled iron compounds in humans.
González H; Mendoza C; Viteri FE
Arch Latinoam Nutr; 2001 Sep; 51(3):217-24. PubMed ID: 11791474
[TBL] [Abstract][Full Text] [Related]
27. Physicochemical and toxicological characterization of a new generic iron sucrose preparation.
Meier T; Schropp P; Pater C; Leoni AL; Khov-Tran VV; Elford P
Arzneimittelforschung; 2011; 61(2):112-9. PubMed ID: 21428246
[TBL] [Abstract][Full Text] [Related]
28. Particle size reduction and encapsulation affect the bioavailability of ferric pyrophosphate in rats.
Wegmüller R; Zimmermann MB; Moretti D; Arnold M; Langhans W; Hurrell RF
J Nutr; 2004 Dec; 134(12):3301-4. PubMed ID: 15570029
[TBL] [Abstract][Full Text] [Related]
29. Effect of iron liposomes on anemia of inflammation.
Yuan L; Geng L; Ge L; Yu P; Duan X; Chen J; Chang Y
Int J Pharm; 2013 Sep; 454(1):82-9. PubMed ID: 23850818
[TBL] [Abstract][Full Text] [Related]
30. Iron bioavailability from fortified fluid milk and petit suisse cheese determined by the prophylactic-preventive method.
Salgueiro J; Leonardi N; Segal M; Shapira N; Shafran N; Carasso Y; Zubillaga M; Goldman C; Barrado A; Janjetic M; Boccio J
Biol Trace Elem Res; 2006 Jan; 109(1):91-6. PubMed ID: 16388106
[TBL] [Abstract][Full Text] [Related]
31. The absorption of iron as supplements in infant cereal and infant formulas.
Rios E; Hunter RE; Cook JD; Smith NJ; Finch CA
Pediatrics; 1975 May; 55(5):686-93. PubMed ID: 165454
[TBL] [Abstract][Full Text] [Related]
32. Iron absorption and bioavailability in rats of micronized dispersible ferric pyrophosphate.
Sakaguchi N; Rao TP; Nakata K; Nanbu H; Juneja LR
Int J Vitam Nutr Res; 2004 Jan; 74(1):3-9. PubMed ID: 15060895
[TBL] [Abstract][Full Text] [Related]
33. Influence of particle dose on the cytotoxicity of hamster and rat pulmonary alveolar macrophage in vitro.
Warshawsky D; Reilman R; Cheu J; Radike M; Rice C
J Toxicol Environ Health; 1994 Aug; 42(4):407-21. PubMed ID: 8051715
[TBL] [Abstract][Full Text] [Related]
34. Effect of ascorbic acid and particle size on iron absorption from ferric pyrophosphate in adult women.
Fidler MC; Davidsson L; Zeder C; Walczyk T; Marti I; Hurrell RF
Int J Vitam Nutr Res; 2004 Jul; 74(4):294-300. PubMed ID: 15580812
[TBL] [Abstract][Full Text] [Related]
35. Bioavailability of elemental iron powder in white wheat bread.
Walter T; Pizarro F; Abrams SA; Boy E
Eur J Clin Nutr; 2004 Mar; 58(3):555-8. PubMed ID: 14985696
[TBL] [Abstract][Full Text] [Related]
36. Relative biological value of iron supplements in processed food products.
Coccodrilli GD; Reussner GH; Thiessen R
J Agric Food Chem; 1976; 24(2):351-3. PubMed ID: 943431
[No Abstract] [Full Text] [Related]
37. Bioavailability studies of a new iron source by means of the prophylactic-preventive method in rats.
Lysionek A; Zubillaga M; Salgueiro J; Caro R; Ettlin E; Boccio J
Biol Trace Elem Res; 2001; 84(1-3):123-8. PubMed ID: 11817683
[TBL] [Abstract][Full Text] [Related]
38. Development of fortified biscuit using NaFeEDTA.
Mohammadi M; Abedi AS; Azizi MH; Ahmadian FS; Pouraram H
J Sci Food Agric; 2011 Aug; 91(11):1984-9. PubMed ID: 21495037
[TBL] [Abstract][Full Text] [Related]
39. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
[TBL] [Abstract][Full Text] [Related]
40. Bioavailability of trivalent iron in oral iron preparations. Therapeutic efficacy and iron absorption from simple ferric compounds and high- or low-molecular weight ferric hydroxide-carbohydrate complexes.
Heinrich HC
Arzneimittelforschung; 1975 Mar; 25(3):420-6. PubMed ID: 1174047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
